Please check out our paper which highlights a combination therapy of MMF and steroid holds promise as a potential treatment strategy for IgAN, especially those displaying active inflammation on kidney biopsy 🩷🌹fernando fervenza, Ladan Zand, Parikshit Duriseti, kireports.org/article/S2468-…

A paradigm shift in diagnosis and classification of membranous nephropathy.

Mayo Clinic consensus report on membranous nephropathy: proposal for a... sciencedirect.com/science/articl…

Be sure to join us for the Mayo Clinic Update Course in Feb 2024 in San Diego, CA. We have a full day of GN and excited to have ⁦Prof Liz Lightstone PhD FRCP FISN 🇬🇧🇮🇱🇺🇦💙💜⁩ ⁦Richard J. Glassock⁩ joining us. Hope to see you all! ce.mayo.edu/internal-medic…

Looking forward to it 😊

Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 is happening February 16 - February 18. Great opportunity to update on general Nephrology and Transplantation! #MayoClinicKidney ce.mayo.edu/internal-medic…

Very exciting study for patients with lupus nephritis!
twitter.com/MayoStudies/st… Ladan Zand Sanjeev Sethi

The inimitable fernando fervenza of Mayo Clinic Nephrology discussing Membranous Nephropathy 💫

Maine-Anjou AAV-GN Registry Patients with persistently negative MPO-ANCA after 18 months of remission-maintenance treatment did not relapse at 60 months. Remission-maintenance treatment can be guided by ANCA status in MPO-AAV-GN.
Our proposed algorithm 👇🏻
pubmed.ncbi.nlm.nih.gov/36526414/ CJASN fernando fervenza

Please checkout my discussion with Jai Radhakrishnan on management of patients with IgAN and FSGS on PeerVoice
Hope you enjoy it 😊

⬇️⬇️⬇️

It was a pleasure to have Dr Zand Ladan Zand from Mayo Clinic Nephrology, providing insights into FSGS, issues with terminology (histopathological lesion) and therapies! Wonderful overview!

I am very excited to announce that we now have a glomerular diseases (GN) fellowship! This will be a one year program (starting July 2024). We are now taking applications. Please see link below for more details: college.mayo.edu/academics/resi…

We are excited to announce that starting July 2024 Mayo Clinic (Rochester) will be offering glomerular diseases (GN) fellowship. The application is now open. See link below for more details. college.mayo.edu/academics/resi…

Niloufar Yarandi Ladan Zand Would be a fantastic opportunity for the fellows interested in GN. Great initiative ! Congratulations Ladan Zand Mayo Clinic Nephrology

I am very excited to announce that we now have a glomerular diseases (GN) fellowship! This will be a one year program (starting July 2024). We are now taking applications. Please see link below for more details: college.mayo.edu/academics/resi…

Have you been diagnosed with Lupus Nephritis? You may be eligible for a clinical trial to study the treatment of class III, IV, & V Lupus Nephritis using a novel therapy. For more information, please visit mayo.edu/research/clini… #MayoClinicMN #LupusNephritis #AskASN #Nephrology

KDIGO guidelines recommend following anti-PLA2R antibody levels as a marker of treatment response in membranous nephropathy. This study found the optimal method to evaluate risk factors for was to use anti-PLA2R antibody & albumin levels after 3 months bit.ly/CJASN0237

Have you been diagnosed with Lupus Nephritis? You may be eligible for a clinical trial to study the treatment of class III, IV, & V Lupus Nephritis using a novel therapy. For more information, please visit mayo.edu/research/clini…

The serum free light chain FLC assay. Tutorial. #MedTwitter #MyelomaVR

Frequently ordered and frequently abnormal. This thread will reduce unnecessary headaches and referrals.

1/ Don’t order it unless you are suspecting myeloma, amyloid or related disorder

Dr. Sandra Herrmann, a Mayo Clinic nephrologist, and her colleagues are leading the way in developing an Onconephrology Clinic designed to address the unique nephrology needs of patients who have had cancer treatment. Learn about their work: mayocl.in/3rctaCq Sandra Herrmann MD, FASN